Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

DIFFUSE LARGE B-CELL LYMPHOMA

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Mariana Bastos-Oreiro

    Principal Investigator

    Hospital General Universitario Gregorio Marañón

  • Alejandro Martín García-Sancho

    Principal Investigator

    Hospital Universitario Salamanca

  • Armando López-Guillermo

    Principal Investigator

    Hospital Clinic of Barcelona